Cold chain News and Research

RSS

Westpak announces formation of cold chain testing division

Westpak Inc., a world class ISO 17025 accredited environmental test laboratory with 2 facilities in California, recently announced the formation of a cold chain testing division dedicated to the testing of packages intended for controlled temperature environments.

13 Aug 2012

Researchers develop new silk-based stabilizer for vaccines and antibiotics

Researchers funded by the National Institutes of Health have developed a new silk-based stabilizer that, in the laboratory, kept some vaccines and antibiotics stable up to temperatures of 140 degrees Fahrenheit.

10 Jul 2012

First sales order for Bluechiip's products from ATCC

Bluechiip Limited - which has developed a unique asset-tracking solution initially for cryogenic sample management in the healthcare and life science industry - today announced that a successful pilot trial of its tracking solution by ATCC, a US-based leader in biological materials management and processes, has led to the first sales order for Bluechiip's products from ATCC.

23 Jun 2012

MIT researchers engineer new jet-injection system

MIT researchers have engineered a device that delivers a tiny, high-pressure jet of medicine through the skin without the use of a hypodermic needle. The device can be programmed to deliver a range of doses to various depths - an improvement over similar jet-injection systems that are now commercially available.

25 May 2012

Guardian examines launch of GAVI-sponsored immunization campaign in Ghana

Ghana's recent "rollout of the rotavirus vaccine and, to much acclaim, a new vaccine against pneumococcal infections, makes it the first country in sub-Saharan African to introduce two new vaccines at the same time," the Guardian reports.

5 May 2012

Study finds feasible and impactful solutions for Nigeria's immunization program

A study released today by the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health has identified the most feasible and impactful solutions for Nigeria's immunization program that could offer the best hope yet for scaling up vaccine access to the nation's most rural areas and taking aim at the country's precipitous number of child deaths.

16 Apr 2012

Soligenix reports positive results from preclinical studies of vaccine thermostabilization technology

Soligenix, Inc., a development stage biopharmaceutical company, announced today results from preclinical studies of its proprietary vaccine thermostabilization technology indicating that Soligenix is able to produce stable vaccine formulations using adjuvants, protein immunogens, and other components that ordinarily would not withstand long temperature variations exceeding customary refrigerated storage conditions.

6 Feb 2012

Marken introduces new global brand and advertising campaign

Marken, a global leader in supporting clinical research logistics, announced the launch of a new global brand and advertising campaign to reflect the unique position that it holds in the pharmaceutical industry.

3 Oct 2011

Needle-free nanopatch vaccine delivery system

The needle-free nanopatch vaccine delivery system is coming soon after a consortium of investors put up $15 million for its development. The money will enable University of Queensland's Professor Mark Kendall to continue his work on the technology. It is described as the biggest breakthrough in vaccine delivery since the invention of the syringe more than 150 years ago.

3 Aug 2011

Intelsius, American Thermal Instruments enter strategic partnership

Intelsius, a global manufacturer and distributor of environmentally sustainable, temperature-controlled and regulatory-compliant packaging solutions, announces a strategic partnership with American Thermal Instruments (ATI), a leader in temperature monitoring, inspections and asset tracking.

18 Jul 2011

EMA publishes concept paper on pharmaceutical cold storage conditions during transport

The European Medicines Agency has published a concept paper on storage conditions during transport. The goal is to create new Good Distribution Practice and GMP guidance and may lead to the need to revise the guideline on declaration of storage conditions.

From IQPC Ltd 17 Feb 2011

GAVI chair calls for greater reductions in vaccine prices for developing countries

On Monday, the same day the GAVI Alliance helped oversee the roll out of a routine pneumococcal vaccine in Kenya, GAVI chairman Dagfinn Hoybraten highlighted the need for greater reductions in vaccine prices in developing countries during an interview with Reuters, the news service reports. The piece examines the funding mechanism in place to finance the pneumococcal vaccines, known as Advance Market Commitment (AMC), as well as the budget shortfall facing the group (Kelland, 2/14).

16 Feb 2011

PakSense launches new class of temperature monitoring device

PakSense, an innovator in sensory solutions for packaging, announced today the launch of the PakSense BIOmed Label product line for use in clinical trials, pharmaceuticals, biologics, vaccines and other healthcare-related material transport.

11 Jan 2011

Researchers develop new vaccine delivery system for rotavirus infection

Researchers have developed a promising new approach to vaccination for rotavirus, a common cause of severe diarrheal disease that is responsible for approximately 500,000 deaths among children in the developing world every year.

16 Nov 2010

PAREXEL International launches temperature recording solution optimized for clinical trial supply process

PAREXEL International Corporation, a leading global biopharmaceutical services organization, today announced that it has introduced an integrated temperature recording solution for study drug transportation as part of its expanded Clinical Logistics Services.

From Parexel 19 Aug 2010

U.S. TSA designates BioStorage Technologies as Certified Cargo Screening Facility

BioStorage Technologies, a global leader in sample management and cold-chain logistics for the pharma and biotech industries, has recently been approved as a Certified Cargo Screening Facility (CCSF) by the U.S. Transportation Security Administration (TSA). The designation establishes BioStorage Technologies as one of the few sample management providers to achieve this clearance level, which allows the company to pre-screen shipments at its facility, thereby avoiding possible screening delays at the airport.

7 Aug 2010

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it continues to make solid progress in its lyophilized recombinant Protective Antigen (rPA) anthrax vaccine development program. The Company has recently demonstrated that its lyophilized rPA vaccine candidate is structurally stable and potent at various temperatures up to and including 70 degrees centigrade.

9 Jul 2010

US physicians concerned about health risk to patients from heat-damaged medicinal products

In a recent Harris Interactive survey of US physicians about the proper storage and handling of temperature-sensitive medicines prescribed and administered to patients, physicians reported being concerned about this issue, and the overwhelming majority are concerned that heat-damaged products resulting from cumulative exposure to temperatures outside the specified temperature range pose a health risk to patients. The announcement of the study findings was made today by Temptime Corporation.

23 Jun 2010

Electron cryomicroscopy helps observe molecules in hydrated state close to natural state

Gene expression takes place in two stages: the transcription of DNA to RNA by an enzyme called RNA polymerase, , followed by the translation of this RNA into proteins, whose behaviour affects the characteristics of each individual.

21 Jun 2010

Statue commemorating 30th anniversary of the eradication of smallpox unveiled

A statue commemorating the 30th anniversary of the eradication of smallpox is being unveiled today in front of the World Health Organization headquarters by the Director-General of the World Health Organization, Dr Margaret Chan.

18 May 2010